Novo Nordisk gains Fast Track status for coramitug to treat ATTR amyloidosis
Novo-Nordisk A/S · Now $44.07
+11% in 7d after detection
Post-detection moves
1h
—
1d
-0.1%
3d
+2.5%
7d
+11%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS